News

Dr. Lal PathLabs Limited has made a further investment in its wholly owned subsidiary, PathLabs Unifiers Private Limited, by subscribing to its equity shares on October 12, 2026, to fund the acquisition of the remaining 30% equity stake in CentraPath Labs Private Limited, another subsidiary of PathLabs Unifiers Private Limited, which will then become wholly owned. The cash consideration for the investment will not exceed Rs 30.3 crore.

Dr. Lal PathLabs FZCO, a wholly-owned subsidiary of Dr. Lal PathLabs Limited, has completed the acquisition of an 80% stake in Sunshine Healthcare Limited (“SHL”) in Ghana, according to a regulatory filing on September 26, 2026, following prior approval on July 24, 2026.

Dr. Lal PathLabs Limited will hold a board meeting on Wednesday, November 04, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30, 2026, the company said in a filing. The trading window for dealing in securities of Dr. Lal PathLabs Limited will be closed from October 1, 2026, to November 06, 2026.

Dr. Lal PathLabs Limited will hold a board meeting on Wednesday, November 04, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2026, according to a regulatory filing. The company’s trading window for securities will be closed from October 1, 2026, to November 06, 2026, in accordance with SEBI regulations.

Dr. Lal PathLabs Limited announced that its board approved the acquisition of a 70% stake in SN Genelab Private Limited (“SN Gene”) from existing shareholders for a cash consideration of up to Rs 168 crore plus a performance-linked earn-out capped at Rs 31.5 crore, with the transaction expected to be completed by November 30, 2026; SN Gene, incorporated on December 16, 2013, reported a turnover of Rs 57.96 crore for fiscal year 2026, Rs 53.36 crore for fiscal year 2025, and Rs 43.27 crore for fiscal year 2024, and is engaged in providing Diagnostics - Genomics services.